COVID-19 Resources Hub

We are highlighting open access, peer-reviewed content with relevance to resource-variable settings. Please check back as we are making new content and adding new resources soon.  Please send suggestions and check out our full Resource Library.

All COVID Resources

View full resources page

Results:

Recently added

Test-to-Treat for COVID-19 is an online, self-paced learning module to build clinical skills for T2T, including identification of patients with suspected COVID-19, triage, IPC, rapid diagnostic testing and management/treatment options.​ The target audience is frontline healthcare workers who may encounter patients with symptoms consistent with possible COVID-19​. The course is available to the public for free on the EpiC Learns LMS platform (www.academy.fhi360.org/epic) in English.

L1
L2
By EpiC
English
Français
Español

This PDSA Tool (Plan, Do, Study, Act) was created by RISE to aid in the implementation of Test-to-Treat programs, and serves as a template for other locations undergoing similar activities.

L1
L2
L3
By RISE
English

This FAQ provides answers to frequently asked questions about the COVID-19 Test to Treat strategy for clinicians, prescribers and health care teams.

L1
L2
L3
By EpiC
English
By EpiC
English
Українська
Español
Pусский
Français
العربية

Information for clinicians on mechanism of action for Molnupiravir, contraindications & indications, general dosage guidelines

L1
L2
L3
By RISE
English

Information for clinicians on mechanism of action for Paxlovid, contraindications & indications, general dosage guidelines.

L1
L2
L3
By RISE
English

Brief overview of the Test-to-Treat activity, answers key questions on purpose and target population

L1
L2
L3
By RISE
English

Information on purpose and use of self-tests in various environments.

L1
L2
L3
By RISE
English

Check out our OCC Job Aid Builder Tool for more free content to make your own job aid. Topics include respiratory care, emergency algorithms, critical care medications, procedures with more topics and more languages coming soon.

L1
L2
L3

This series of supportive tools are based on the WHO Therapeutics and COVID-19: living guideline. They are intended to provide supportive information for healthcare workers who are prescribing, administering and monitoring patients receiving nirmatrelvir-ritonavir for non-severe COVID-19.

L1
L2
L3
By WHO / OMS
English

This calculator allows users to estimate the number of courses of oral antivirals that might be required during a calendar period, based on infection rate inputs.

T2T Quantification Tool
L2
L3
By STAR-UCSF
English

Guidelines on COVID-19 Test to Treat, by the Africa Centres for Disease Control and Prevention (Guidance to Africa Union Member States)

L1
L2
L3
By Africa CDC
English

Cet algorithme et ce guide de mise en œuvre sont destinés à aider les cliniciens au point de service à initier un traitement antiviral oral pour la COVID-19. Sur la base des données, le nirmatrelvir/ritonavir (NMV/r) est l'agent préféré, suivi du molnupiravir.

Ces ressources ont été créées par les partenaires EpIC, RISE, STAR-UCSF.

L1
L2
L3
By OpenCriticalCare.org
Français
English

Este algoritmo es para ayudar a los médicos en el punto de atención a iniciar el tratamiento con antivíricos por vía oral para el COVID-19. En función de los datos, nirmatrelvir/ritonavir (NMV/r) se prefiere, seguido de molnupiravir.

Estos recursos fueron creados por los colaboradores EpIC, RISE, STAR-UCSF.

L1
L2
L3
By OpenCriticalCare.org
English
Español
L1
L2
L3
By STAR-UCSF
1h 1min
English

Menu

Feedback

Not 
at all

Very 


Your message was sent successfully.